All lobbying filings

SIGHTLINE ADVOCACY, LLC

Lobbying for AMGEN · Biotechnology

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to drug pricing; Issues related to cardiovascular disease awareness and treatment. S.Res.464 - A resolution designating September 2025 as "National Cholesterol Education Month" and September 30, 2025, as "LDL-C Awareness Day"

Bills named in this filing 1

S. Res. 464
A resolution designating September 2025 as "National Cholesterol Education Month" and September 30, 2025, as "LDL-C Awa…

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.